Fusion Antibodies to Attend HAH 2015

Share Article

Fusion Antibodies have announced that the company will be attending the 2015 Human Antibodies and Hybridomas Conference.

HAH 2015 logo
This will be Fusion Antibodies’ 9th year at the event.

Fusion Antibodies today announce that they will be attending the 2015 Human Antibodies and Hybridomas Conference, to be held 28-30th of October at the University of Lausanne, Switzerland. Conference activities will include keynote lectures, presentations and contributed papers. The event will bring together top scientists from universities, bioscience companies and research institutes across Europe, North America and Asia.

HAH 2015 will cover nine main topics:

  •     Anti-infective antibodies
  •     Autoimmunity
  •     Cancer
  •     Clinical applications
  •     Emerging technologies
  •     Infectious diseases
  •     Intellectual property and legal issues
  •     Molecular biology
  •     Therapeutic antibodies

This will be Fusion Antibodies’ 9th year in attendance at the event. Managing Director, Dr Paul Kerr is part of the Scientific Advisory committee and Technical Director Dr Richard Buick will be presenting “Fast track humanization of rabbit antibodies: Optimization of an algorithm based on a broad rabbit B-cell repertoire.”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Kerr
@FsnAntibodies
Follow >
Fusion Antibodies
since: 02/2011
Like >
Fusion Antibodies Ltd

Follow us on
Visit website